Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer
  2. Chen, M.; Shabashvili, D.; Nawab, A.; Yang, S. X.; Dyer, L. M.; Brown, K. D.; Hollingshead, M.; Hunter, K. W.; Kaye, F. J.; Hochwald, S. N.; Marquez, V. E.; Steeg, P.; Zajac-Kaye, M.
  3. Molecular Cancer Therapeutics. 2012, Feb; 11(2): 370-382.
  1. 2.   Apoptosis Is the Essential Target of Selective Pressure against p53, whereas Loss of Additional p53 Functions Facilitates Carcinoma Progression
  2. Lu, X. D. L. X. D.; Yang, C. Y.; Yin, C. Y.; Van Dyke, T.; Simin, K.
  3. Molecular Cancer Research. 2011, Apr; 9(4): 430-439.
  1. 3.   Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B
  2. Martin, A. G.; Trama, J.; Crighton, D.; Ryan, K. M.; Fearnhead, H. O.
  3. Aging-Us. 2009, Mar; 1(3): 335-349.
  1. 4.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 5.   Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells
  2. Yang, Y. L.; Ludwig, R. L.; Jensen, J. P.; Pierre, S. A.; Medaglia, M. V.; Davydov, I. V.; Safiran, Y. J.; Oberoi, P.; Kenten, J. H.; Phillips, A. C.; Weissman, A. M.; Vousden, K. H.
  3. Cancer Cell. 2005, JUN; 7(6): 547-559.
  1. 6.   p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase
  2. Zhao, Y. F.; Chaiswing, L.; Velez, J. M.; Batinic-Haberle, I.; Colburn, N. H.; Oberley, T. D.; St Clair, D. K.
  3. Cancer Research. 2005, MAY 1; 65(9): 3745-3750.
  1. 7.   Proteome analysis of DNA damage-induced neuronal death using high throughput mass spectrometry
  2. Johnson, M. D.; Yu, L. R.; Conrads, T. P.; Kinoshita, Y.; Uo, T.; Matthews, J. D.; Lee, S. W.; Smith, R. D.; Veenstra, T. D.; Morrison, R. S.
  3. Journal of Biological Chemistry. 2004 279(25): 26685-26697.
  1. 8.   Regulating the p53 system through ubiquitination
  2. Yang, Y. L.; Li, C. C. H.; Weissman, A. M.
  3. Oncogene. 2004 23(11): 2096-2106.
  1. 9.   Transgenic expression in mouse lung reveals distinct biological roles for the adenovirus type 5 E1A 243-and 289-amino-acid proteins
  2. Yang, Y. P.; McKerlie, C.; Borenstein, S. H.; Lu, Z.; Schito, M.; Chamberlain, J. W.; Buchwald, M.
  3. Journal of Virology. 2002 76(17): 8910-8919.
  1. 10.   Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways
  2. Weber, H. O.; Samuel, T.; Rauch, P.; Funk, J. O.
  3. Oncogene. 2002 21(20): 3207-3212.
  1. 11.   Activation of the p53 tumor suppressor protein
  2. Vousden, K. H.
  3. Biochimica Et Biophysica Acta-reviews on Cancer. 2002 1602(1): 47-59.
  1. 12.   E2F-1 induced apoptosis
  2. Phillips, A. C.; Vousden, K. H.
  3. Apoptosis. 2001 6(3): 173-182.
  1. 13.   PUMA, a novel proapoptotic gene, is induced by p53
  2. Nakano, K.; Vousden, K. H.
  3. Molecular Cell. 2001 7(3): 683-694.
  1. 14.   Regulation and function of the p53 tumor suppressor protein
  2. Ryan, K. M.; Phillips, A. C.; Vousden, K. H.
  3. Current Opinion in Cell Biology. 2001 13(3): 332-337.
  1. 15.   Role of NF-kappa B in p53-mediated programmed cell death
  2. Ryan, K. M.; Ernst, M. K.; Rice, N. R.; Vousden, K. H.
  3. Nature. 2000 404(6780): 892-897.
  1. 16.   Mechanisms of p53-mediated apoptosis
  2. Bates, S.; Vousden, K. H.
  3. Cellular and Molecular Life Sciences. 1999 55(1): 28-37.
  1. 17.   Regulation and activation of p53 and its family members
  2. Lohrum, M. A. E.; Vousden, K. H.
  3. Cell Death and Differentiation. 1999 6(12): 1162-1168.
  1. 18.   Characterization of Structural P53 Mutants Which Show Selective Defects in Apoptosis But Not Cell Cycle Arrest
  2. Ryan, K. M.; Vousden, K. H.
  3. Molecular and Cellular Biology. 1998 18(7): 3692-3698.
  1. 19.   Regulation of Mdm2-Directed Degradation By the C Terminus of P53
  2. Kubbutat, M. H. G.; Ludwig, R. L.; Ashcroft, M.; Vousden, K. H.
  3. Molecular and Cellular Biology. 1998 18(10): 5690-5698.
  1. 20.   Perturbation of the P53 Response By Human Papillomavirus Type 16 E7
  2. Hickman, E. S.; Bates, S.; Vousden, K. H.
  3. Journal of Virology. 1997 71(5): 3710-3718.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel